Illumina (ILMN) Competitors $75.06 +0.28 (+0.37%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Do analysts recommend A or ILMN? Agilent Technologies currently has a consensus target price of $146.25, indicating a potential upside of 38.52%. Illumina has a consensus target price of $138.70, indicating a potential upside of 85.11%. Given Illumina's stronger consensus rating and higher possible upside, analysts plainly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.46Illumina 1 Sell rating(s) 10 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.48 Does the MarketBeat Community favor A or ILMN? Illumina received 247 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.04% of users gave Agilent Technologies an outperform vote while only 65.28% of users gave Illumina an outperform vote. CompanyUnderperformOutperformAgilent TechnologiesOutperform Votes86671.04% Underperform Votes35328.96% IlluminaOutperform Votes111365.28% Underperform Votes59234.72% Which has more volatility and risk, A or ILMN? Agilent Technologies has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Does the media favor A or ILMN? In the previous week, Illumina had 3 more articles in the media than Agilent Technologies. MarketBeat recorded 32 mentions for Illumina and 29 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.27 beat Illumina's score of 0.93 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 22 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 16 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 7 Negative mention(s) 0 Very Negative mention(s) Positive Is A or ILMN more profitable? Agilent Technologies has a net margin of 19.27% compared to Illumina's net margin of -27.95%. Agilent Technologies' return on equity of 25.56% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies19.27% 25.56% 13.47% Illumina -27.95%13.37%5.49% Do insiders and institutionals believe in A or ILMN? 87.4% of Agilent Technologies shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 0.3% of Agilent Technologies shares are owned by company insiders. Comparatively, 0.2% of Illumina shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has better earnings and valuation, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.53B4.61$1.29B$4.3524.27Illumina$4.37B2.71-$1.22B-$7.68-9.76 SummaryAgilent Technologies beats Illumina on 11 of the 19 factors compared between the two stocks. Remove Ads Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.87B$4.16B$5.32B$7.55BDividend YieldN/A0.61%5.11%4.34%P/E Ratio-9.7627.4921.6217.70Price / Sales2.714.16373.9693.31Price / Cash20.7236.0838.1534.64Price / Book5.001.776.383.95Net Income-$1.22B-$83.57M$3.20B$247.24M7 Day Performance2.01%7.66%5.15%5.01%1 Month Performance-12.46%-3.86%-7.51%-6.50%1 Year Performance-41.03%-36.98%7.35%-2.61% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.5982 of 5 stars$75.06+0.4%$138.70+84.8%-41.2%$11.89B$4.37B-9.7711,500AAgilent Technologies4.6639 of 5 stars$103.43+0.4%$150.83+45.8%-27.1%$29.44B$6.51B23.7417,900Positive NewsGap UpMTDMettler-Toledo International4.1377 of 5 stars$1,034.95+1.2%$1,380.50+33.4%-17.4%$21.61B$3.87B25.5918,000News CoveragePositive NewsGap UpHigh Trading VolumeWATWaters4.129 of 5 stars$324.41-0.2%$401.31+23.7%+0.9%$19.30B$2.96B30.338,200Gap UpTECHBio-Techne4.8999 of 5 stars$52.22+1.0%$81.25+55.6%-24.0%$8.27B$1.20B52.863,100Analyst RevisionPositive NewsGap UpCRLCharles River Laboratories International4.7719 of 5 stars$133.13-2.8%$189.77+42.5%-58.7%$6.81B$4.05B887.6621,800Short Interest ↓Analyst RevisionNews CoverageGap UpBIOBio-Rad Laboratories4.6579 of 5 stars$226.97+0.6%$395.20+74.1%-18.3%$6.36B$2.57B-3.498,200Short Interest ↓Positive NewsGap UpBRKRBruker4.6169 of 5 stars$38.42+5.4%$68.00+77.0%-55.7%$5.82B$3.37B50.508,520Gap UpHigh Trading VolumePACBPacific Biosciences of California2.6019 of 5 stars$1.30+5.3%$2.46+89.8%-57.1%$388.70M$154.01M-0.80730Positive NewsGap DownHBIOHarvard Bioscience3.672 of 5 stars$0.37-6.6%$4.50+1,103.2%-90.6%$16.48M$94.14M-1.13490Analyst ForecastGap UpTMOThermo Fisher Scientific4.9348 of 5 stars$437.21-0.2%$653.23+49.4%-22.5%$164.87B$42.88B26.44130,000Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ILMN Stock Free ILMN Stock Alerts